Vanguard Personalized Indexing Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Sell
4,512
-60
-1% -$27.7K 0.02% 581
2026
Q1
$2.2M Sell
4,572
-177
-4% -$90.6K 0.02% 568
2025
Q4
$2.67M Buy
4,749
+124
+3% +$70.4K 0.03% 502
2025
Q3
$2.38M Buy
4,625
+876
+23% +$382K 0.02% 526
2025
Q2
$1.18M Buy
3,749
+299
+9% +$89.8K 0.01% 800
2025
Q1
$1.05M Buy
3,450
+38
+1% +$12.8K 0.02% 760
2024
Q4
$1.13M Buy
3,412
+303
+10% +$103K 0.02% 722
2024
Q3
$1.04M Buy
3,109
+73
+2% +$27.7K 0.02% 751
2024
Q2
$1.25M Buy
3,036
+508
+20% +$201K 0.02% 581
2024
Q1
$1.02M Sell
2,528
-621
-20% -$218K 0.02% 647
2023
Q4
$965K Buy
3,149
+1,506
+92% +$407K 0.02% 669
2023
Q3
$398K Buy
1,643
+207
+14% +$52.9K 0.01% 992
2023
Q2
$345K Sell
1,436
-45
-3% -$9.35K 0.01% 1062
2023
Q1
$279K Buy
1,481
+531
+56% +$110K 0.01% 1148
2022
Q4
$202K Buy
+950
New +$190K 0.01% 1155

Other funds holding MEDP

Vanguard Personalized Indexing Management's MEDP Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Medpace (MEDP) stake by 1.3% in Q2 2026, selling an estimated $27.7K and leaving 4,512 shares worth $2.39M. The position accounts for 0.02% of the portfolio, ranked #581.

Vanguard Personalized Indexing Management first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.67M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Vanguard Personalized Indexing Management held 4,512 shares of Medpace worth $2.39M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 60 Medpace shares in Q2 2026, an estimated $27.7K.
  • Medpace made up 0.02% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #581 holding.
  • Vanguard Personalized Indexing Management first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Vanguard Personalized Indexing Management's Medpace position peaked at $2.67M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.